IRIS
FORNARO, MICHELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.906
EU - Europa 2.434
AS - Asia 2.009
AF - Africa 81
SA - Sud America 43
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 4
Totale 7.484
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.857
IT - Italia 1.776
SG - Singapore 929
CN - Cina 581
VN - Vietnam 449
NL - Olanda 142
SE - Svezia 107
UA - Ucraina 87
CI - Costa d'Avorio 76
IE - Irlanda 60
FI - Finlandia 45
CA - Canada 42
RU - Federazione Russa 41
DE - Germania 39
GB - Regno Unito 37
FR - Francia 36
BR - Brasile 27
RO - Romania 12
TR - Turchia 12
CL - Cile 8
HU - Ungheria 8
IN - India 8
AU - Australia 7
IS - Islanda 7
BG - Bulgaria 6
EC - Ecuador 6
ES - Italia 6
JP - Giappone 6
HR - Croazia 5
CH - Svizzera 4
EU - Europa 4
IR - Iran 4
PK - Pakistan 4
PL - Polonia 4
AE - Emirati Arabi Uniti 3
BZ - Belize 3
GR - Grecia 3
ID - Indonesia 3
JO - Giordania 3
RS - Serbia 3
BE - Belgio 2
HK - Hong Kong 2
HN - Honduras 2
KR - Corea 2
MA - Marocco 2
MX - Messico 2
PT - Portogallo 2
TW - Taiwan 2
ZA - Sudafrica 2
AR - Argentina 1
EG - Egitto 1
SI - Slovenia 1
SM - San Marino 1
TH - Thailandia 1
VE - Venezuela 1
Totale 7.484
Salva come PNG Salva come JPEG
Città #
Singapore 755
Dong Ket 449
Chandler 359
Millbury 342
Princeton 224
Des Moines 203
Nanjing 201
Santa Clara 179
Naples 149
Rome 132
Amsterdam 126
Milan 85
Beijing 77
Wilmington 75
Boston 69
Ashburn 62
Shenyang 62
Lawrence 58
Hebei 57
Nanchang 53
Norwalk 50
Napoli 47
Jiaxing 43
Ottawa 32
Casavatore 30
Tianjin 30
Turin 30
Houston 27
Catania 25
Redwood City 23
Bari 20
Florence 19
Changsha 17
Dublin 17
Genoa 16
Jacksonville 15
Trieste 14
Cagliari 13
Fairfield 12
Livorno 12
Woodbridge 12
Padova 11
Seattle 11
Torino 11
Buffalo 10
Bologna 9
Castelnuovo Rangone 9
Kronberg 9
Timisoara 9
Boardman 8
Helsinki 8
Lappeenranta 8
Sezze 8
Urbino 8
Ann Arbor 7
Palermo 7
Parma 7
Pescara 7
Reykjavík 7
Salerno 7
Scarperia 7
Atlanta 6
Brescia 6
Città di Castello 6
Kayseri 6
Loja 6
Perugia 6
Portici 6
Sassari 6
Sofia 6
West Jordan 6
Brooklyn 5
Caivano 5
Frankfurt am Main 5
Guangzhou 5
Novara 5
Paris 5
Quartu Sant'Elena 5
Rho 5
Riccione 5
Shenzhen 5
São Paulo 5
Treviso 5
Viareggio 5
Alghero 4
Andover 4
Arzano 4
Bollate 4
Capaccio 4
Cava de' Tirreni 4
Council Bluffs 4
Elmas 4
Formia 4
Gallipoli 4
Grado 4
Grumo Nevano 4
Legnano 4
Montesilvano Marina 4
Monza 4
New York 4
Totale 4.578
Salva come PNG Salva come JPEG
Nome #
Disturbo bipolare e malattie disreattive: una relazione complessa 623
Disturbo borderline e spettro bipolare: una ricerca epidemiologica 206
Comorbidità tra Disturbo da Deficit dell'Attenzione e Iperattività nell'adulto e Distubo Bipolare - prevalenza e caratteristiche cliniche in uno studio preliminare 124
Valutazione elettroretinografica (ERG) in pazienti con depressione maggiore in trattamento con duloxetina: differenza tra “responders” e “non-responders” quale possibile indice di un pattern biologico differenziale. 112
“XLIV Congresso Nazionale della Società Italiana di Psichiatria (SIP) 2006”. Palacongressi d’Abruzzo, Montesilvano (Pescara) 15-20 ottobre 2006. (simposio dal titolo “L’identità dello Psichiatra: le opinioni degli specializzandi in Psichiatria italiani” – abstract book pp.247. 106
Miglioramento clinico con bupropione della Sindrome delle Gambe Senza Riposo indotto dal trattamento con mirtazapna e duloxetina in un paziente affetto da Depressione Maggiore 88
Psychological distress in serious mental illness patients during the COVID-19 outbreak and one-month mass quarantine in Italy 65
Current and future perspectives on the Major Depressive Disorder: Focus on the new multimodal antidepressant Vortioxetine 62
Obsessive-Compulsive Aspects and Pathological Gambling in an Italian Sample 60
Factor structure and reliability of the Italian adaptation of the Hypomania Check List-32, second revision (HCL-32-R2). 58
Prevalence and correlates of major depressive disorder, bipolar disorder and schizophrenia among nursing home residents without dementia: systematic review and meta-analysis 58
Associate Editor 57
Studio dell'Asse Ipotalamo-Ipofisi-Surrene nei pazienti con Depressione Maggiore prima e dopo trattamento con Reboxetina 54
Impulsività e disturbi d’ansia: il ruolo della ciclotimia 52
Efficacia e sicurezza dell’asenapina in pazienti con episodi maniacali e misti associati a disturbo bipolare I 46
Adjunctive agomelatine therapy in the treatment of acute bipolar II depression: a preliminary open label study 45
Treatment-Resistant to Antipsychotics: A Resistance to Everything? Psychotherapy in Treatment-Resistant Schizophrenia and Nonaffective Psychosis: A 25-Year Systematic Review and Exploratory Meta-Analysis 45
The Relationships between Cholesterol and Suicide: An Update 43
Agomelatine beyond borders: current evidences of its efficacy in disorders other than major depression 41
May second generation long-acting injectable antipsychotics be prescribed as a first-line treatment of first episode in patients with schizophrenia? An overview. 40
Preclinical considerations about affective disorders and pain: A broadly intertwined, yet often under-explored, relationship having major clinical implications 40
Impulsività e disturbi d’ansia: uno studio caso-controllo 39
The role of melatonin in mood disorders 38
Agomelatine in the treatment of panic disorder 38
Affective temperaments are associated with specific clusters of symptoms and psychopathology: A cross-sectional study on bipolar disorder inpatients in acute manic, mixed, or depressive relapse. 37
New advances in the treatment of generalized anxiety disorder: The multimodal antidepressant vortioxetine 37
Adjunctive vortioxetine for SSRI-resistant major depressive disorder: a "real-world" chart review study 37
Effect of agomelatine treatment on C-reactive protein levels in patients with major depressive disorder: an exploratory study in “real-world,” everyday clinical practice 36
Treating the Synapse in Major Psychiatric Disorders: The Role of Postsynaptic Density Network in Dopamine-Glutamate Interplay and Psychopharmacologic Drugs Molecular Actions 36
Adjunctive agomelatine therapy in the treatment of acute bi¬polar II depression: a preliminary open label study (MONOGRAFIA segnalata dalla International Society for Bipolar Disorder - ISBD) 36
Alexithymia and Suicide Risk in Psychiatric Disorders: A Mini-Review 36
C-reactive protein level and its relationship with suicide risk and alexithymia among newly diagnosed, drug-naïve patients with non-affective psychosis 35
Predictors of hospitalization length of stay among re-admitted treatment-resistant Bipolar Disorder inpatients 35
Are atypical depression, borderline personality disorder and bipolar II disorder overlapping manifestations of a common cyclothymic diathesis? 35
Celiac disease and ADHD: mini-review and critique 35
Adding 5-hydroxytryptamine receptor type 3 antagonists may reduce drug-induced nausea in poor insight obsessive-compulsive patients taking off-label doses of selective serotonin reuptake inhibitors: a 52-week follow-up case report 35
Clinical and psychopathological features associated with treatment-emergent mania in bipolar-II depressed outpatients exposed to antidepressants 34
Academic Editor 34
Electroretinographic modifications induced by agomelatine: a novel avenue to the understanding of the claimed antidepressant effect of the drug? 34
Agomelatine treatment of major depressive disorder in Parkinson's disease: a case series 34
"Aspetti etologici e terapeutici della comorbilità tra Depressione e Disturbo Post-Traumatico da Stress" 34
Incidence, prevalence and clinical correlates of antidepressant-emergent mania in bipolar depression: a systematic review and meta-analysis 33
Cariprazine (RGH-188): A new pharmacological target option for the treatment of schizophrenia, bipolar disorders and depression? 33
Psychological perspective of medication adherence in transplantation 33
Eradicating suicide at its roots: Preclinical bases and clinical evidence of the efficacy of ketamine in the treatment of suicidal behaviors 33
Alexithymia and Breast Cancer Surgery: A Systematic Review 32
Somatopsychic correlates and quality of life of the dialyzed patient: a cross-sectional study 32
A comparative meta-analysis of TEMPS scores across mood disorder patients, their first-degree relatives, healthy controls, and other psychiatric disorders 32
The identification of biomarkers predicting acute and maintenance lithium treatment response in bipolar disorder: A plea for further research attention 32
"Novel Psychopharmacology for Depressive Disorders" 32
Alexithymia, Suicide Ideation, C-Reactive Protein, and Serum Lipid Levels Among Outpatients with Generalized Anxiety Disorder 31
Prevalence and clinical features associated with bipolar disorder polypharmacy: a systematic review 31
VEGF plasma level variations in duloxetine-treated patients with major depression 31
Discriminative hypomania checklist-32 factors in unipolar and bipolar major depressive patients 31
“Duloxetina e Bupropione in Medicina Generale” Aggiornamento ECM per Medici di Medicina Generale. Centro Ricerca G. De Lisio (Coordinatore Scientifico, Prof. G. Perugi), Pisa 15-12-2008. 31
An Update on Glutamatergic System in Suicidal Depression and on the role of Esketamine 31
Alexithymia, resilience, somatic sensations and their relationships with suicide ideation in drug naïve patients with first-episode major depression: An exploratory study in the “real world” everyday clinical practice 31
Treatment of antipsychotic-induced hyperprolactinemia: an update on the role of the dopaminergic receptors D2 partial agonist aripiprazole 30
Targeting the Noradrenergic System in Posttraumatic Stress Disorder: A Systematic Review and Meta-Analysis of Prazosin Trials 30
Lurasidone in the Treatment of Bipolar Depression: Systematic Review of Systematic Reviews 30
Tinnitus psychopharmacology: A comprehensive review of its pathomechanisms and management 30
Clozapine-related Sudden Pericarditis in a Patient Taking Long Acting Aripiprazole and Valproate: A Case Report 30
The burden of mood-disorder/cerebrovascular disease comorbidity: essential neurobiology, psychopharmacology, and physical activity interventions 30
“Continuum Ansia e Depressione”. Presentazione casi clinici. (Boehringer-Ingelheim). Camogli (Genova), 17-18 aprile 2009 (co-relatori: G. Biggio, G. Cerveri, C. Mencacci, G.R. Perna, R.L. Picci, V. Rosso, R. Torta, M. Vaggi). 29
Aripiprazole for relapse prevention and craving in alcohol use disorder: Current evidence and future perspectives 29
Impulsività e disturbo da panico: il ruolo della ciclotimia 29
Aderenza al trattamento in pazienti bipolari tipo-II in fase acuta depressiva: correlati psicopatologici del temperamento ciclotimico e “therapeutic sensation seeking” in risposta alla incapacità di sopportazione del dolore soggettivo 29
Adherence to Chronic Therapies in Psychiatry: From Treatment to Cure.The Relevance of Therapeutic Relationship 29
Cotard’s Syndrome: Clinical Case Presentation and Literature Review 29
Different measures of impulsivity in patients with anxiety disorders: a case control study 29
Progress in bipolar disorder drug design toward the development of novel therapeutic targets: a clinician's perspective 29
“Agomelatina – Innovazione nel trattamento della depressione maggiore” (Servier). Genova 28 ottobre 2010, co-relatori, Prof. Popoli, Prof. L. Ferrannini, Dr. M. Vaggi. 29
The ‘dead man walking’ disorder: an update on Cotard’s syndrome 29
Cotard's Syndrome after breast surgery successfully treated with aripiprazole augmentation of escitalopram: a case report 28
EU-Finder “Factors Influencing Depression Endpoints Research” (studio osservazionale su pazienti in trattamento per Episodio Depressivo Maggiore in atto); anno 2004-2005.. 28
The emergence of loss of efficacy during antidepressant drug treatment for major depressive disorder: An integrative review of evidence, mechanisms, and clinical implications 28
Prominent autistic traits and subthreshold bipolar/mixed features of depression in severe anorexia nervosa 28
The prevalence, odds and predictors of lifespan comorbid eating disorder among people with a primary diagnosis of bipolar disorders, and vice-versa: Systematic review and meta-analysis 28
Prevalence and diagnostic distribution of medically unexplained painful somatic symptoms across 571 major depressed outpatients 27
Obsessive-compulsive disorder with bipolar diathesis following isotretinoin therapy remitting upon treatment with olanzapine and fluvoxamine 27
Aspirin and incident depressive symptoms: A longitudinal cohort study over 8 years 27
Agomelatine reversal of escitalopram-induced apathy: a case report 27
Sensation seeking in major depressive patients: relationship to sub-threshold bipolarity and cyclothymic temperament 27
“Resistenza alla gestione farmacologica della depressione bipolare resistente: Refrattarietà vs. tolleranza a litio in pazienti precedentemente responsivi. Inquadramento clinico, cenni neurobiologici, e prospettive terapeutiche.” – Evento: “Unveiling the dark side of the mood: nuove prospettive diagnostiche e terapeutiche per il trattamento dei disturbi depressivi”. Giulianova (Teramo), 6 Ottobre 2016. 27
Predictors of Treatment Resistance Across Different Clinical Subtypes of Depression: Comparison of Unipolar vs. Bipolar Cases 27
Is there a biosignature for lithium response in bipolar disorder? Evidence and implications 27
Efficacy and safety of long acting injectable atypical antipsychotics: a review 26
The Novel Antipsychotic Cariprazine (RGH-188): State-of-the-Art in the Treatment of Psychiatric Disorders 26
Does the "Silver Bullet" Lose its Shine Over the Time? Assessment of Loss of Lithium Response in a Preliminary Sample of Bipolar Disorder Outpatients 26
Alexithymia, responsibility attitudes and suicide ideation among outpatients with obsessive-compulsive disorder: An exploratory study 26
Alexithymia and its relationships with acute phase proteins and cytokine release: an updated review 26
The argument of antidepressant drugs in the treatment of bipolar depression: mixed evidence or mixed states? 26
When Clozapine Fails: Augmentation Strategies in the Management of Clozapine-Resistant Schizophrenia 26
A comprehensive review on the efficacy of S-Adenosyl-L-methionine in Major Depressive Disorder 25
Safety of antipsychotics for the treatment of schizophrenia: a focus on the adverse effects of clozapine 25
Effetti collaterali oftalmologici dei farmaci antipsicotici 25
Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls 25
Psychopathological aspects of kidney transplantation: Efficacy of a multidisciplinary team 25
The relationship between drive to thinness, conscientiousness and bulimic traits during adolescence: a comparison between younger and older cases in 608 healthy volunteers 25
Atypical Antipsychotics in the Treatment of Acute Bipolar Depression with Mixed Features: A Systematic Review and Exploratory Meta-Analysis of Placebo-Controlled Clinical Trials 25
Totale 4.432
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.177
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.177
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020249 0 0 8 5 14 19 5 4 8 112 58 16
2020/2021920 24 37 39 36 28 107 53 25 45 27 31 468
2021/20221.411 83 14 33 57 30 94 51 68 93 103 147 638
2022/20231.389 307 98 48 59 114 141 36 90 196 145 102 53
2023/20241.614 71 171 145 116 80 60 139 183 73 105 290 181
2024/20251.294 526 745 23 0 0 0 0 0 0 0 0 0
Totale 8.023